Table of Contents
Lymphoma
Volume 2012, Article ID 341629, 12 pages
http://dx.doi.org/10.1155/2012/341629
Research Article

Analysis of NF- B Pathway Proteins in Pediatric Hodgkin Lymphoma: Correlations with EBV Status and Clinical Outcome—A Children's Oncology Group Study

1Texas Children's Hospital and Dan L. Duncan Cancer Center, Baylor College of Medicine, Suite 750, 1102 Bates Street, Houston, TX 77030, USA
2Department of Pathology, Texas Children's Hospital and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA
3Department of Pathology, SUNY Upstate Medical University, 750 E. Adam Street, Syracuse, NY 13210, USA
4Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA
5Division of Biostatistics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA

Received 3 August 2012; Accepted 6 November 2012

Academic Editor: Juan F. Garci­a

Copyright © 2012 Terzah M. Horton et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Schmitz, J. Stanelle, M. L. Hansmann, and R. Küppers, “Pathogenesis of classical and lymphocyte-predominant hodgkin lymphoma,” Annual Review of Pathology, vol. 4, pp. 151–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Kuppers, “The biology of Hodgkin's lymphoma,” Nature Reviews Cancer, vol. 9, no. 1, pp. 15–27, 2009. View at Publisher · View at Google Scholar
  3. S. C. Sun and S. C. Ley, “New insights into NF-κB regulation and function,” Trends in Immunology, vol. 29, no. 10, pp. 469–478, 2008. View at Publisher · View at Google Scholar
  4. S. Mathas, A. Lietz, I. Anagnostopoulos et al., “c-FLIP mediates resistance of hodgkin/reed-sternberg cells to death receptor-induced apoptosis,” Journal of Experimental Medicine, vol. 199, no. 8, pp. 1041–1052, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Kashkar, C. Haefs, H. Shin et al., “XIAP-mediated caspase inhibition in hodgkin's lymphoma-derived B cells,” Journal of Experimental Medicine, vol. 198, no. 2, pp. 341–347, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. R. K. Thomas, A. Kallenborn, C. Wickenhauser et al., “Constitutive expression of c-FLIP in hodgkin and reed-sternberg cells,” American Journal of Pathology, vol. 160, no. 4, pp. 1521–1528, 2002. View at Google Scholar · View at Scopus
  7. G. Z. Rassidakis, L. J. Medeiros, T. P. Vassilakopoulos et al., “BCL-2 expression in hodgkin and reed-sternberg cells of classical hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens,” Blood, vol. 100, no. 12, pp. 3935–3941, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Zhang, H. Quan, J. Ng, and M. E. Stepanavage, “Some statistical methods for multiple endpoints in clinical trials,” Controlled Clinical Trials, vol. 18, no. 3, pp. 204–221, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. R. C. Bargou, C. Leng, D. Krappmann et al., “High-level nuclear NF-κB and Oct-2 is a common feature of cultured hodgkin/reed-sternberg cells,” Blood, vol. 87, no. 10, pp. 4340–4347, 1996. View at Google Scholar · View at Scopus
  10. M. Nonaka, R. Horie, K. Itoh, T. Watanabe, N. Yamamoto, and S. Yamaoka, “Aberrant NF-κB2/p52 expression in hodgkin/reed-sternberg cells and CD30-transformed rat fibroblasts,” Oncogene, vol. 24, no. 24, pp. 3976–3986, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. T. F. E. Barth, J. I. Martin-Subero, S. Joos et al., “Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical hodgkin lymphoma,” Blood, vol. 101, no. 9, pp. 3681–3686, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Mathas, K. Jöhrens, S. Joos et al., “Elevated NF-κB p50 complex formation and Bcl-3 expression in classical hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas,” Blood, vol. 106, no. 13, pp. 4287–4293, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. M. Izumi and E. D. Kieff, “The epstein-barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 23, pp. 12592–12597, 1997. View at Google Scholar · View at Scopus
  14. E. D. C. McFarland, K. M. Izumi, and G. Mosialos, “Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-κB,” Oncogene, vol. 18, no. 49, pp. 6959–6964, 1999. View at Google Scholar · View at Scopus
  15. S. Pai, B. J. O'Sullivan, L. Cooper, R. Thomas, and R. Khanna, “RelB nuclear translocation mediated by C-terminal activator regions of epstein-barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells,” Journal of Virology, vol. 76, no. 4, pp. 1914–1921, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. I. E. Wartz, K. M. O'Rourke, H. Zhou et al., “De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling,” Nature, vol. 430, no. 7000, pp. 694–699, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. J. F. Garcia, F. I. Camacho, M. Morente et al., “Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays,” Blood, vol. 101, no. 2, pp. 681–689, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. C. V. Hedvat, A. Hegde, R. S. K. Chaganti et al., “Application of tissue microarray technology to the study of non-hodgkin's and hodgkin's lymphoma,” Human Pathology, vol. 33, no. 10, pp. 968–974, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Wang and C. R. Taylor, “Apoptosis and cell cycle-related genes and proteins in classical hodgkin lymphoma: application of tissue microarray technique,” Applied Immunohistochemistry and Molecular Morphology, vol. 11, no. 3, pp. 206–213, 2003. View at Google Scholar · View at Scopus
  20. A. Sánchez-Aguilera, C. Montalbán, P. De La Cueva et al., “Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic hodgkin lymphoma,” Blood, vol. 108, no. 2, pp. 662–668, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. C. Bargou, F. Emmerich, D. Krappmann et al., “Constitutive nuclear factor-κb-RelA activation is required for proliferation and survival of hodgkin's disease tumor cells,” Journal of Clinical Investigation, vol. 100, no. 12, pp. 2961–2969, 1997. View at Google Scholar · View at Scopus
  22. F. Feuerhake, J. L. Kutok, S. Monti et al., “NFκB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes,” Blood, vol. 106, no. 4, pp. 1392–1399, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. P. J. Jost and J. Ruland, “Aberrant NF-κB signaling in lymphoma: mechanisms, consequences, and therapeutic implications,” Blood, vol. 109, no. 7, pp. 2700–2707, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Küppers, “Molecular biology of hodgkin lymphoma,” American Society of Hematology, pp. 491–496, 2009. View at Google Scholar · View at Scopus
  25. E. Cabannes, G. Khan, F. Aillet, R. F. Jarrett, and R. T. Hay, “Mutations in the IkBa gene in hodgkin's disease suggest a tumour suppressor role for IκBα,” Oncogene, vol. 18, no. 20, pp. 3063–3070, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Emmerich, M. Meiser, M. Hummel et al., “Overexpression of I kappa B alpha without inhibition of NF-κB activity and mutations in the I kappa B alpha gene in reed-sternberg cells,” Blood, vol. 94, no. 9, pp. 3129–3134, 1999. View at Google Scholar · View at Scopus
  27. F. Emmerich, S. Theurich, M. Hummel et al., “Inactivating I kappa B epsilon mutations in hodgkin/reed-sternberg cells,” Journal of Pathology, vol. 201, no. 3, pp. 413–420, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Kato, M. Sanada, I. Kato et al., “Frequent inactivation of A20 in B-cell lymphomas,” Nature, vol. 459, no. 7247, pp. 712–716, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Schmitz, M. L. Hansmann, V. Bohle et al., “TNFAIP3 (A20) is a tumor suppressor gene in hodgkin lymphoma and primary mediastinal B cell lymphoma,” Journal of Experimental Medicine, vol. 206, no. 5, pp. 981–989, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Steidl, A. Telenius, S. P. Shah et al., “Genome-wide copy number analysis of hodgkin reed-sternberg cells identifies recurrent imbalances with correlations to treatment outcome,” Blood, vol. 116, no. 3, pp. 418–427, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Horie, T. Watanabe, Y. Morishita et al., “Ligand-independent signaling by overexpressed CD30 drives NF-κB activation in hodgkin-reed-sternberg cells,” Oncogene, vol. 21, no. 16, pp. 2493–2503, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Younes, A. Garg, and B. B. Aggarwal, “Nuclear transcription factor-kappaB in Hodgkin's disease,” Leukemia and Lymphoma, vol. 44, no. 6, pp. 929–935, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Krappmann, F. Emmerich, U. Kordes, E. Scharschmidt, B. Dörken, and C. Scheidereit, “Molecular mechanisms of constitutive NF-κB/Rel activation in hodgkin/reed-sternberg cells,” Oncogene, vol. 18, no. 4, pp. 943–953, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Kilger, A. Kieser, M. Baumann, and W. Hammerschmidt, “Epstein-barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor,” The EMBO Journal, vol. 17, no. 6, pp. 1700–1709, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. L. S. Young and P. G. Murray, “Epstein-barr virus and oncogenesis: from latent genes to tumours,” Oncogene, vol. 22, no. 33, pp. 5108–5121, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. A. G. Eliopoulos, C. W. Dawson, G. Mosialos et al., “CD40-induced growth inhibition in epithelial cells is mimicked by epstein-barr virus-encoded LMP1: involvement of TRAF3 as a common mediator,” Oncogene, vol. 13, no. 10, pp. 2243–2254, 1996. View at Google Scholar · View at Scopus
  37. F. Schneider, J. Neugebauer, J. Griese et al., “The viral oncoprotein LMP1 exploits TRADD for signaling by masking its apoptotic activity,” PLoS Biology, vol. 6, no. 1, p. e8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Khan, “Epstein-barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of hodgkin's lymphoma?” Experimental Hematology, vol. 34, no. 4, pp. 399–406, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. I. S. Lee, S. H. Kim, H. G. Song, and S. H. Park, “The molecular basis for the generation of hodgkin and reed-sternberg cells in hodgkin's lymphoma,” International Journal of Hematology, vol. 77, no. 4, pp. 330–335, 2003. View at Google Scholar · View at Scopus
  40. Y. Saitoh, N. Yamamoto, M. Z. Dewan et al., “Overexpressed NF-κB-inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and hodgkin reed-sternberg cells,” Blood, vol. 111, no. 10, pp. 5118–5129, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Allen, K. Saigal, L. Nottingham, P. Arun, Z. Chen, and C. Van Waes, “Bortezomib-induced apoptosis with limited clinical response is accompanied by inhibition of canonical but not alternative nuclear factor-κB subunits in head and neck cancer,” Clinical Cancer Research, vol. 14, no. 13, pp. 4175–4185, 2008. View at Publisher · View at Google Scholar · View at Scopus